Active, not recruitingPhase 3NCT03386539
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
Studying Acquired immunodeficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Christopher S Almond, MD, MPHStanford University
- Intervention
- Everolimus(drug)
- Enrollment
- 211 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2018 – 2024
Study locations (25)
- Children's of Alabama, Birmingham, Alabama, United States
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Loma Linda University, Loma Linda, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- UCLA Mattel Children's Hospital, Los Angeles, California, United States
- Stanford University, Palo Alto, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Florida Congenital Heart Center, Gainesville, Florida, United States
- Joe DiMaggio Children's Hospital, Hollywood, Florida, United States
- Children's Healthcare of Atlanta Emory, Atlanta, Georgia, United States
- Lurie Children's Hospital, Chicago, Illinois, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- University of Michigan Medical Center, Ann Arbor, Michigan, United States
- Washington University in St. Louis School of Medicine, St Louis, Missouri, United States
- +10 more locations on ClinicalTrials.gov
Collaborators
Stanford University · United States Department of Defense
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03386539 on ClinicalTrials.govOther trials for Acquired immunodeficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07298785Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot StudyUniversity of California, San Francisco
- ENROLLING BY INVITATIONNANCT07192419Promoting Aging and Thriving With HIVIndiana University
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07182838Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic MixHan Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- RECRUITINGNANCT07064785Video-Intervention to Inspire Treatment Adherence for Life for AdolescentsBaylor College of Medicine
- RECRUITINGNANCT06999928Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIVIndiana University
- ACTIVE NOT RECRUITINGNANCT07074899Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in PeruFred Hutchinson Cancer Center
- RECRUITINGNANCT06389565Change My Story Task Shifted Mental Health InterventionMassachusetts General Hospital
- ACTIVE NOT RECRUITINGNANCT06913660ALHIV Smartphone Game StudyEmory University